证券时报e公司讯,港股歌礼制药-B持续上涨,现涨超21%。此前公司公告称,扩大利托那韦口服片剂产能,并公布口服直接抗新冠病毒药物研发管线。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.